ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 138 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $91,520 | -18.9% | 3,582 | -9.0% | 0.06% | -16.4% |
Q2 2023 | $112,884 | -12.3% | 3,936 | -26.7% | 0.07% | -5.6% |
Q1 2023 | $128,647 | +2.1% | 5,367 | -27.8% | 0.07% | +7.6% |
Q4 2022 | $126,030 | +5.0% | 7,431 | -8.2% | 0.07% | +37.5% |
Q3 2022 | $120,000 | -5.5% | 8,092 | +0.7% | 0.05% | +2.1% |
Q2 2022 | $127,000 | +4.1% | 8,039 | +77.4% | 0.05% | -14.5% |
Q1 2022 | $122,000 | -31.5% | 4,532 | -5.6% | 0.06% | -17.9% |
Q4 2021 | $178,000 | -37.1% | 4,803 | -18.8% | 0.07% | -46.4% |
Q3 2021 | $283,000 | +34.1% | 5,913 | -5.1% | 0.12% | +43.7% |
Q2 2021 | $211,000 | +83.5% | 6,229 | +123.7% | 0.09% | +77.6% |
Q1 2021 | $115,000 | -3.4% | 2,785 | +1.5% | 0.05% | 0.0% |
Q4 2020 | $119,000 | – | 2,743 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DFPG INVESTMENTS, LLC | 456,390 | $5,541,000 | 3.62% |
DAFNA Capital Management LLC | 173,914 | $1,890,000 | 0.65% |
One68 Global Capital, LLC | 19,861 | $216,000 | 0.47% |
Diametric Capital, LP | 51,982 | $565,000 | 0.41% |
ARK Investment Management | 1,383,756 | $15,041,000 | 0.38% |
EAM Investors, LLC | 52,833 | $574,000 | 0.13% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 31,404 | $341,000 | 0.05% |
Nikko Asset Management Americas, Inc. | 280,548 | $3,050,000 | 0.05% |
MGO ONE SEVEN LLC | 14,900 | $161,000 | 0.04% |
Qube Research & Technologies Ltd | 67,702 | $736,000 | 0.02% |